Q4 2024 Holdings
Filed 2025-02-14 | 183 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $124.8M | 2,254,797 | 8.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $75.7M | 8,429,500 | 5.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $59.4M | 2,161,200 | 3.9% |
| Evolus Inc(EOLS) | COM | 30052C107 | $55.2M | 4,997,399 | 3.7% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $51.2M | 1,237,107 | 3.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $47.8M | 2,492,925 | 3.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $45.9M | 1,555,600 | 3.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $41.5M | 4,893,847 | 2.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $33.2M | 8,068,058 | 2.2% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $32.7M | 2,700,000 | 2.2% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $31.6M | 700,000 | 2.1% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $30.8M | 270,000 | 2.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $27.5M | 1,500,000 | 1.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $25.1M | 300,000 | 1.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $24.6M | 300,000 | 1.6% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $23.6M | 1,850,000 | 1.6% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $22.1M | 766,940 | 1.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $20.5M | 150,000 | 1.4% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $19.8M | 2,750,000 | 1.3% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $19.1M | 142,569 | 1.3% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $17.6M | 1,330,879 | 1.2% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $17.6M | 317,500 | 1.2% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $17.2M | 140,000 | 1.1% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $16.1M | 1,100,000 | 1.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $16.0M | 4,788,912 | 1.1% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $15.7M | 1,497,500 | 1.0% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $15.6M | 26,600 | 1.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $14.6M | 450,000 | 1.0% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $13.5M | 400,000 | 0.9% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $13.0M | 270,000 | 0.9% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $12.9M | 1,100,000 | 0.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $12.9M | 320,000 | 0.9% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $12.7M | 1,400,000 | 0.8% |
| Moderna Inc(MRNA) | COM | 60770K107 | $12.5M | 300,000 | 0.8% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $12.4M | 628,609 | 0.8% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $11.7M | 1,330,097 | 0.8% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $11.3M | 2,353,307 | 0.7% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $11.2M | 921,138 | 0.7% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $10.5M | 266,500 | 0.7% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $10.4M | 3,900,000 | 0.7% |
| Hillevax Inc | COM | 43157M102 | $10.2M | 4,920,000 | 0.7% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $9.8M | 150,000 | 0.7% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $9.7M | 800,000 | 0.6% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $9.7M | 281,200 | 0.6% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $9.4M | 550,000 | 0.6% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $9.4M | 750,000 | 0.6% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $9.2M | 640,000 | 0.6% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $9.1M | 1,480,975 | 0.6% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $8.6M | 5,900,000 | 0.6% |
| Bausch Plus Lomb Corp(BLCO) | COMMON SHARES | 071705107 | $8.1M | 450,000 | 0.5% |